<?xml version="1.0" encoding="UTF-8"?>
<p>Arterial hypertension is among the most frequent comorbidities associated in patients infected with SARS-CoV-2, with an estimated prevalence of 15–30% in most of the studies from China, with a higher value in patients who ultimately had severe COVID-19 infection [
 <xref rid="sfaa082-B12" ref-type="bibr">12</xref>, 
 <xref rid="sfaa082-B13" ref-type="bibr">13</xref>, 
 <xref rid="sfaa082-B28" ref-type="bibr">28–30</xref>]. However, these values might be higher due to the likely underreporting of pre-existing conditions in China [
 <xref rid="sfaa082-B31" ref-type="bibr">31</xref>]. Importantly, the presence of underlying hypertension may be a risk factor for severe patients compared with non-severe patients, according to a recent meta-analysis of eight studies including 46 248 COVID-19 patients [
 <xref rid="sfaa082-B32" ref-type="bibr">32</xref>].
</p>
